Download the full-sized PDF of Structural and Inhibitory Studies of LL-Diaminopimelate Aminotransferase and Investigation of Methods for Small Peptide CrystallizationDownload the full-sized PDF



Permanent link (DOI):


Export to: EndNote  |  Zotero  |  Mendeley


This file is in the following communities:

Graduate Studies and Research, Faculty of


This file is in the following collections:

Theses and Dissertations

Structural and Inhibitory Studies of LL-Diaminopimelate Aminotransferase and Investigation of Methods for Small Peptide Crystallization Open Access


Other title
LL-Diaminopimelate Aminotransferase
Subtilosin A
Type of item
Degree grantor
University of Alberta
Author or creator
Fan, Chenguang
Supervisor and department
Vederas, John C. (Department of Chemistry)
Examining committee member and department
Keillor, Jeffrey W. (Department of Chemistry, University of Ottawa)
Campbell, Robert E. (Department of Chemistry)
Bundle, David R. (Department of Chemistry)
Lemieux, M. Joanne (Department of Biochemistry)
Gibbs-Davis, Julianne M. (Department of Chemistry)
Department of Chemistry

Date accepted
Graduation date
Doctor of Philosophy
Degree level
The pyridoxal-5'-phosphate (PLP)-dependent enzyme LL-diaminopimelate aminotransferase (LL-DAP-AT) catalyzes a key step in the biosynthesis of L-lysine in plants and Chlamydia. In this thesis, studies of mechanistic and inhibitory aspects of LL-DAP-AT are described. Two LL-DAP-ATs from Arabidopsis thaliana and Chlamydia trachomatis were studied using X-ray crystallography. Furthermore, synthetic analogues of PLP-glutamate adduct 87, PLP-LL-diaminopimelate adduct 89, and pyridoxamine-5′-phosphate-tetrahydrodipicolinate (THDP) adduct 91 were co-crystallized with LL-DAP-AT. It was found that the hydrolysis product of THDP is the true substrate for this enzymatic transamination reaction. Crystallographic studies provide insights regarding the broader substrate specificity of Chlamydia LL-DAP-AT compared to the Arabidopsis enzyme. Since mammals require lysine from their diet, specific inhibitors of LL-DAP-AT could potentially serve as non-toxic antibiotics. A high-throughput screening study has been performed on a 29,201-compound library. N-(3-(Hydrazinecarbonyl)naphthalen-2-yl)benzenesulfonamide (122) was identified as the best hit (IC50 ~ 5 μM). In addition, three potential pharmacophores (derivatives of rhodanine, barbiturate, and thiobarbiturate) were identified. Structure-activity relationship (SAR) studies were conducted based on lead compound 122 and rhodanine derivatives. N-(5-Fluoro-2-(hydrazinecarbonyl)phenyl)benzenesulfonamide (155) was identified as a two-fold better inhibitor compared to the lead compound. It was found that a free hydrazide and a phenylsulfonamide were essential for inhibition. These two moieties needed to be attached to an aryl system, but further substitution of the aryl group was tolerated. These results may provide insight for future inhibitor design. In the second portion of this thesis, efforts toward development of methods for small peptide (< 5 kDa) crystallization are described. A co-crystallization approach was investigated, which involves linking a small peptide to a small molecule inhibitor to a readily crystallizable enzyme. Upon mixing, the small peptide may be co-crystallized with the enzyme. Subtilosin A (SubA, 191), a 35-amino acid circular bacteriocin, was selected for this co-crystallization study. Two bioconjugates, N-acetyl glucosamine (GlcNAc)-SubA and N,N′,N′′-triacetylchitotriose ((GlcNAc)3)-SubA, were prepared toward co-crystallization with lysozyme. A bioconjugate of arylsulfonamide-SubA was also synthesized for co-crystallization with carbonic anhydrase II (CAII). Current attempts towards co-crystallization were unsuccessful, likely due to the poor solubility of these bioconjugates. Efforts are underway towards co-crystallization by potentially improving the solubility of the bioconjugates.
Permission is hereby granted to the University of Alberta Libraries to reproduce single copies of this thesis and to lend or sell such copies for private, scholarly or scientific research purposes only. Where the thesis is converted to, or otherwise made available in digital form, the University of Alberta will advise potential users of the thesis of these terms. The author reserves all other publication and other rights in association with the copyright in the thesis and, except as herein before provided, neither the thesis nor any substantial portion thereof may be printed or otherwise reproduced in any material form whatsoever without the author's prior written permission.
Citation for previous publication

File Details

Date Uploaded
Date Modified
Audit Status
Audits have not yet been run on this file.
File format: pdf (Portable Document Format)
Mime type: application/pdf
File size: 57754778
Last modified: 2015:10:18 01:35:49-06:00
Filename: Fan_Chenguang_Fall 2012.pdf
Original checksum: 3aa6bac86bb386a1b58935bc917f7d23
Well formed: true
Valid: true
Status message: File header gives version as 1.4, but catalog dictionary gives version as 1.3
Status message: Too many fonts to report; some fonts omitted. Total fonts = 1766
File title: Final Thesis-Chenguang Fan-submission
File author: W2-57
Page count: 282
Activity of users you follow
User Activity Date